-transparent.png){kind=logo}
Seventy patients with Hodgkin's disease have been treated with a combination of chlorambucil, vinblastine, procarbazine and prednisolone (Ch1VPP). The complete remission rate of 75-7% compares well with that produced by other combinations. The combination is non-toxic, easily administered and can be given safely to outpatients. Its main advantage is that it is far less upsetting to patients than combinations containing nitrogen mustard.
Related Publications
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
March 1980,
Orvosi hetilap,
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
June 1979,
Cancer treatment reviews,
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
January 1991,
European journal of cancer (Oxford, England : 1990),
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
November 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
January 1994,
Acta haematologica Polonica,
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
January 1979,
Cancer chemotherapy and pharmacology,
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
November 1991,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
March 1989,
Cancer,
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
January 2003,
The National medical journal of India,
T J McElwain, and
J Toy, and
E Smith, and
M J Peckham, and
D E Austin
March 1965,
Annals of internal medicine,
